172 related articles for article (PubMed ID: 36266030)
1. Esophageal Cancer Genetics and Clinical Translation.
Jajosky A; Fels Elliott DR
Thorac Surg Clin; 2022 Nov; 32(4):425-435. PubMed ID: 36266030
[TBL] [Abstract][Full Text] [Related]
2. The management of localized esophageal squamous cell carcinoma: Western approach.
Zaidi N; Kelly RJ
Chin Clin Oncol; 2017 Oct; 6(5):46. PubMed ID: 29129086
[TBL] [Abstract][Full Text] [Related]
3. New therapeutic strategies for squamous cell cancer and adenocarcinoma.
Wijnhoven BPL; Toxopeus ELA; Vallböhmer D; Knoefel WT; Krasna MJ; Perez K; van Rossum PSN; Ruurda JP; van Hillegersberg R; Schiesser M; Schneider P; Felix VN
Ann N Y Acad Sci; 2013 Oct; 1300():213-225. PubMed ID: 24117644
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy.
Taylor Ripley R; Surman DR; Diggs LP; Trepel JB; Lee MJ; Ryan J; Davis JL; Steinberg SM; Hernandez JM; Hoang C; Kenney CM; Bond CD; Kunst TF; Letai A; Schrump DS
BMC Gastroenterol; 2018 Jun; 18(1):94. PubMed ID: 29933761
[TBL] [Abstract][Full Text] [Related]
6. Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy.
Alakus H; Bollschweiler E; Hölscher AH; Warnecke-Eberz U; Frazer KA; Harismendy O; Lowy AM; Mönig SP; Eberz PM; Maus M; Drebber U; Siffert W; Metzger R
Ann Surg Oncol; 2014 Dec; 21(13):4375-82. PubMed ID: 24986238
[TBL] [Abstract][Full Text] [Related]
7. The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma.
Adachi Y; Ohashi H; Imsumran A; Yamamoto H; Matsunaga Y; Taniguchi H; Nosho K; Suzuki H; Sasaki Y; Arimura Y; Carbone DP; Imai K; Shinomura Y
Tumour Biol; 2014 Feb; 35(2):973-85. PubMed ID: 24026884
[TBL] [Abstract][Full Text] [Related]
8. Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer: Results of the Prospective Cologne Esophageal Response Prediction (CERP) Study.
Bollschweiler E; Hölscher AH; Herbold T; Metzger R; Alakus H; Schmidt H; Drebber U; Warnecke-Eberz U
Ann Surg; 2016 Nov; 264(5):839-846. PubMed ID: 27741011
[TBL] [Abstract][Full Text] [Related]
9. The value of epigenetic markers in esophageal cancer.
Zhang XM; Guo MZ
Front Med China; 2010 Dec; 4(4):378-84. PubMed ID: 21107750
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in treating oesophageal cancer.
Harada K; Rogers JE; Iwatsuki M; Yamashita K; Baba H; Ajani JA
F1000Res; 2020; 9():. PubMed ID: 33042518
[TBL] [Abstract][Full Text] [Related]
11. p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.
Cescon DW; Bradbury PA; Asomaning K; Hopkins J; Zhai R; Zhou W; Wang Z; Kulke M; Su L; Ma C; Xu W; Marshall AL; Heist RS; Wain JC; Lynch TJ; Christiani DC; Liu G
Clin Cancer Res; 2009 May; 15(9):3103-9. PubMed ID: 19383811
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre.
Saigí M; Oliva M; Aliste L; Calvo M; Hormigo G; Serra Ò; Boladeras A; Farran L; Robles J; Creus G; Paúles MJ; Gornals JB; de Lama E; Borràs JM; Sala N; Galán M
PLoS One; 2017; 12(9):e0184737. PubMed ID: 28931046
[TBL] [Abstract][Full Text] [Related]
13. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic biomarkers in esophageal cancer.
Kaz AM; Grady WM
Cancer Lett; 2014 Jan; 342(2):193-9. PubMed ID: 22406828
[TBL] [Abstract][Full Text] [Related]
15. Chemoradiation Therapy as Definitive Treatment of Esophageal Cancer.
Wang SX; Marshall MB
Surg Clin North Am; 2021 Jun; 101(3):443-451. PubMed ID: 34048764
[TBL] [Abstract][Full Text] [Related]
16. [Role of miRNA in the diagnosis, prognosis and treatment of esophageal cancer].
Cao XF; Li SQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):161-4. PubMed ID: 21575511
[No Abstract] [Full Text] [Related]
17. New directions in perioperative management of locally advanced esophagogastric cancer.
Burtness B; Ilson D; Iqbal S
Am Soc Clin Oncol Educ Book; 2014; ():e172-8. PubMed ID: 24857100
[TBL] [Abstract][Full Text] [Related]
18. Molecular landscape of esophageal cancer: implications for early detection and personalized therapy.
Talukdar FR; di Pietro M; Secrier M; Moehler M; Goepfert K; Lima SSC; Pinto LFR; Hendricks D; Parker MI; Herceg Z
Ann N Y Acad Sci; 2018 Dec; 1434(1):342-359. PubMed ID: 29917250
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive genomic characterization of esophageal squamous cell carcinoma: from prognostic analysis to in vivo assay.
Chen YB; Jia WH
Chin J Cancer; 2016 Aug; 35(1):76. PubMed ID: 27515178
[TBL] [Abstract][Full Text] [Related]
20. Circulating Tumor Cells in Esophageal Cancer.
Hoeppner J; Kulemann B
Oncol Res Treat; 2017; 40(7-8):417-422. PubMed ID: 28693013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]